<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03493308</url>
  </required_header>
  <id_info>
    <org_study_id>09-CED/2018</org_study_id>
    <nct_id>NCT03493308</nct_id>
  </id_info>
  <brief_title>Pain Neuroscience Education and Exercise in Institutionalized Older Adults With Pain</brief_title>
  <official_title>Pain Neuroscience Education and Exercise in Institutionalized Older Adults With Pain: A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aveiro University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aveiro University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objectives of this study are to:

        -  Evaluate recruitment procedures and adherence rates;

        -  Evaluate the ability to understand the concepts of pain neurophysiology;

        -  Evaluate the acceptability of an intervention program based on pain neuroscience
           education and exercise by institutionalized older adults and the institutions where they
           are.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be older adults with pain that are institutionalized and assess the
      feasibility of implementing an intervention consisting of pain neuroscience education in
      addition to exercise. It is antecipated that the intervention will consist of 1 to 2 sessions
      per week during 8 weeks and will be delivered in small groups. Participants will be assessed
      for pain intensity, duration, catastrophizing, fear of movement, knowledge of pain
      neuroscience, depression and performance.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">April 12, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessed using the vertical numeric rating scale that assesses pain intensity (range 0-10 and higher values are indicative of higher pain intensity)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>9 weeks</time_frame>
    <description>Assessed using the vertical numeric rating scale that assesses pain intensity (range 0-10 and higher values are indicative of higher pain intensity)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed using the vertical numeric rating scale that assesses pain intensity (range 0-10 and higher values are indicative of higher pain intensity)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain location</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessed using a body chart where the patients identifies the painful body segments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain location</measure>
    <time_frame>9 weeks</time_frame>
    <description>Assessed using a body chart where the patients identifies the painful body segments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain location</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed using a body chart where the patients identifies the painful body segments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain frequency</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessed using a closed question on pain frequency for the last week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain frequency</measure>
    <time_frame>9 weeks</time_frame>
    <description>Assessed using a closed question on pain frequency for the last week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain frequency</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed using a closed question on pain frequency for the last week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessed using the Geriatric Depression Scale (range 0-15 and values of 5 or higher are indicative of depression)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>9 weeks</time_frame>
    <description>Assessed using the Geriatric Depression Scale (range 0-15 and values of 5 or higher are indicative of depression)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed using the Geriatric Depression Scale (range 0-15 and values of 5 or higher are indicative of depression)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knowledge of pain neuroscience</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessed using the pain neurophysiology questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knowledge of pain neuroscience</measure>
    <time_frame>9 weeks</time_frame>
    <description>Assessed using the pain neurophysiology questionnaire (range 0-19 and higher values are indicative of more knowledge on pain neurophysiology)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knowledge of pain neuroscience</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed using the pain neurophysiology questionnaire (range 0-19 and higher values are indicative of more knowledge on pain neurophysiology)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain catastrophizing</measure>
    <time_frame>Baseline</time_frame>
    <description>assessed using the Pain Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain catastrophizing</measure>
    <time_frame>9 weeks</time_frame>
    <description>assessed using the Pain Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain catastrophizing</measure>
    <time_frame>3 months</time_frame>
    <description>assessed using the Pain Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fear of movement</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessed using the TAMPA Scale, which assesses fear of movement (range: 13-52 and higher values are indicative of higher levels of fear of movement)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fear of movement</measure>
    <time_frame>9 weeks</time_frame>
    <description>Assessed using the TAMPA Scale (range: 13-52 and higher values are indicative of higher levels of fear of movement)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fear of movement</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed using the TAMPA Scale (range: 13-52 and higher values are indicative of higher levels of fear of movement)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait velocity</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessed using the gait velocity test - the time, in seconds, that each participant takes to walk 4 meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait velocity</measure>
    <time_frame>9 weeks</time_frame>
    <description>Assessed using the gait velocity test - the time, in seconds, that each participant takes to walk 4 meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait velocity</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed using the gait velocity test - the time, in seconds, that each participant takes to walk 4 meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postural control</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessed using the Timed up and go test - the time, in seconds, that it takes to stand from a chair, walk 3 meters, turn, walk another 3 meters to sit in the chair.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postural control</measure>
    <time_frame>9 weeks</time_frame>
    <description>Assessed using the Timed up and go test - the time, in seconds, that it takes to stand from a chair, walk 3 meters, turn, walk another 3 meters to sit in the chair.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postural control</measure>
    <time_frame>3 months</time_frame>
    <description>Assessed using the Timed up and go test - the time, in seconds, that it takes to stand from a chair, walk 3 meters, turn, walk another 3 meters to sit in the chair.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Pain neuroscience and exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will received an 8 week intervention consisting of pain neuroscience education and exercise. Pain neuroscience education will be conducted in line with international guidelines, covering the neurophysiology of pain, transition from from acute to chronic pain and the nervous system ability to modulate the pain experience. exercise will include general exercise and dance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pain neuroscience education</intervention_name>
    <description>PNE will be conducted in line with international guidelines and will cover the neurophysiology of pain, transition from acute to chronic pain and the nervous system ability to modulate the pain experience.</description>
    <arm_group_label>Pain neuroscience and exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Exercise will be provided in different formats including general exercise, strengthening, dance.</description>
    <arm_group_label>Pain neuroscience and exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be institutionalized in any type of response (nursing home, day care, ...), be able to
             read and write, have chronic pain (defined as pain lasting 3 months or more and felt
             at least once a week during these 3 months ) anywhere in the body, and have a
             statement from the institution's physician authorizing participation in the exercise
             sessions.

        Exclusion Criteria:

          -  Have any contra-indication to exercise and have cognitive limitations (evaluated
             through the Montreal Cognitive Assessment questionnaire).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anabela Silva, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aveiro University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lar de Fermentelos</name>
      <address>
        <city>√Ågueda</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2018</study_first_submitted>
  <study_first_submitted_qc>April 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2018</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aveiro University</investigator_affiliation>
    <investigator_full_name>Anabela G Silva</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

